Analysis of the frequency distribution of five single-nucleotide polymorphisms of the MTRRgene in a Chinese pediatric population with acute lymphoblastic leukemia

Pharmacotherapy. 2022 Jun;42(6):442-452. doi: 10.1002/phar.2685. Epub 2022 Apr 26.

Abstract

Study objective: The objective of the present study was to examine the frequency distribution of five single-nucleotide polymorphisms (SNPs; rs1801394 A>G, rs1532268 C>T, rs162036 A>G, rs10380 C>T, and rs9332 C>T) of the methionine synthase reductase (MTRR) gene, their effects on methotrexate (MTX) concentration, and the risk of relapse in a Chinese pediatric population with acute lymphoblastic leukemia (ALL).

Design: This was a retrospective single-center study, and all analyses were exploratory.

Setting: Pediatric Department of Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

Patients: One hundred and forty pediatric patients with ALL.

Intervention: All patients were treated according to the Chinese Children's Leukemia Group (CCLG)-ALL 2008 protocol.

Measurements and main results: Serum MTX concentrations were measured using fluorescence polarization immunoassay. Genotyping of five SNPs was performed using the Sequenom MassARRAY iPLEX platform. Chinese children with ALL had a significantly lower frequency of rs1801394 G than European (EUR) and South Asian (SAS) populations; significantly lower frequency of rs1532268 T than American (AMR), EUR, and SAS populations; and significantly lower frequencies of rs162036 G, rs10380 T, and rs9332 T than African and AMR populations (p < 0.01). Seven haplotypes were observed, with the ACACC being the most common haplotype (49.9%) in our study. The median dose-normalized concentrations of MTX in serum at 24 h in children with rs1532268 CT and TT genotypes were significantly higher than those with CC genotype (p = 0.04). Compared with children with AA-CC-AA-CC-CC diplotype, a significantly higher risk of relapse was observed in children with AG-CC-AA-CC-CC and AG-CC-AG-CC-CC diplotypes (p = 0.03 and 0.003, respectively).

Conclusions: The present study confirmed the ethnic differences in the distribution of MTRR rs1801394, rs1532268, rs162036, rs10380, and rs9332 polymorphisms. The rs1532268 polymorphism had greater effects on MTX disposition. The AG-CC-AA-CC-CC and AG-CC-AG-CC-CC diplotypes were significantly associated with higher risk of relapse of ALL.

Keywords: acute lymphoblastic leukemia; methionine synthase reductase; methotrexate; single-nucleotide polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Ferredoxin-NADP Reductase* / genetics
  • Gene Frequency
  • Genotype
  • Humans
  • Methotrexate / therapeutic use
  • Polymorphism, Single Nucleotide
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / enzymology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Recurrence
  • Retrospective Studies

Substances

  • Ferredoxin-NADP Reductase
  • methionine synthase reductase
  • Methotrexate